Literature DB >> 29722663

…of Radiation Oncology, Biology, and Physics.

Jay W Burmeister1, Monica W Tracey2, Sara E Kacin3, Michael M Dominello4, Michael C Joiner5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29722663      PMCID： PMC5937706          DOI： 10.1016/j.ijrobp.2018.01.045

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  1 in total

1.  IBPRO - A Novel Short-Duration Teaching Course in Advanced Physics and Biology Underlying Cancer Radiotherapy.

Authors:  Michael C Joiner; Monica W Tracey; Sara E Kacin; Jay W Burmeister
Journal:  Radiat Res       Date:  2017-03-22       Impact factor: 2.841
  1 in total
  9 in total

1.  Three discipline collaborative radiation therapy (3DCRT) special debate: We should treat all cancer patients with hypofractionation.

Authors:  Michael Green; Samantha J Van Nest; Emilie Soisson; Kathryn Huber; Yixiang Liao; William McBride; Michael M Dominello; Jay Burmeister; Michael C Joiner
Journal:  J Appl Clin Med Phys       Date:  2020-06       Impact factor: 2.102

2.  Three discipline collaborative radiation therapy (3DCRT) special debate: I would treat all early-stage NSCLC patients with SBRT.

Authors:  Pranshu Mohindra; Amit Sawant; Robert J Griffin; Narottam Lamichhane; Erina Vlashi; Meng Xu-Welliver; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-02-22       Impact factor: 2.102

3.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States should build additional proton therapy facilities.

Authors:  Steve Braunstein; Li Wang; Wayne Newhauser; Todd Tenenholz; Yi Rong; Albert van der Kogel; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-02-08       Impact factor: 2.102

4.  Three discipline collaborative radiation therapy (3DCRT) special debate: Equipment development is stifling innovation in radiation oncology.

Authors:  Leonard Kim; Stephanie Markovina; Samantha J Van Nest; Subarna Eisaman; Lakshmi Santanam; Julie M Sullivan; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-05-25       Impact factor: 2.102

5.  Three Discipline Collaborative Radiation Therapy (3DCRT) special debate: In the future, at least 20% of NIH funding for radiotherapy research should be allocated to non-oncologic applications.

Authors:  Krisha Howell; Martha Matuszak; Charles A Maitz; Subarna H Eisaman; Laura Padilla; Stephen L Brown; Michael C Joiner; Michael M Dominello; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.102

6.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility.

Authors:  Eleanor A Blakely; Bruce Faddegon; Christopher Tinkle; Charles Bloch; Michael Dominello; Robert J Griffin; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.243

7.  Three discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune response.

Authors:  Clemens Grassberger; Kathryn Huber; Naduparambil K Jacob; Michael D Green; Peter Mahler; Joann Prisciandaro; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.102

8.  Three discipline collaborative radiation therapy (3DCRT) special debate: Peer review in radiation oncology is more effective today than 20 years ago.

Authors:  Anis Ahmad; Lakshmi Santanam; Abhishek A Solanki; Laura Padilla; Erina Vlashi; Patrizia Guerrieri; Michael M Dominello; Jay Burmeister; Michael C Joiner
Journal:  J Appl Clin Med Phys       Date:  2020-11-24       Impact factor: 2.243

9.  Three discipline collaborative radiation therapy (3DCRT) special debate: FLASH radiotherapy needs ongoing basic and animal research before implementing it to a large clinical scale.

Authors:  Patrizia Guerrieri; Naduparambil K Jacob; Peter G Maxim; Amit Sawant; Samantha J Van Nest; Pranshu Mohindra; Michael M Dominello; Jay W Burmeister; Michael C Joiner
Journal:  J Appl Clin Med Phys       Date:  2022-02-01       Impact factor: 2.102
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.